Workflow
NCS Multistage(NCSM)
icon
Search documents
NCS Multistage (NCSM) Conference Transcript
2025-08-21 15:00
Summary of NCS Multistage Holdings Conference Call Company Overview - NCS Multistage Holdings is a technology-focused oilfield services and equipment company, selling directly to oil and natural gas producers such as Chevron, Conoco, and BP [4][5] - Competes with larger companies like Schlumberger and Halliburton, focusing on areas where it can achieve leadership and attractive margins [5] - Operates a capital-light business model, outsourcing manufacturing to minimize capital investment and generate free cash flow [6] Financial Highlights - Recent market capitalization and enterprise value are just below $90 million, with trailing twelve-month EBITDA of $26 million and free cash flow of $10 million [7] - Revenue grew by 14% or $20 million in 2024, with expectations for continued growth in 2025 despite a challenging market [23] - Gross margin approximately 40%, with an improvement of 200 basis points in 2024 compared to 2023 [24] - Free cash flow generation expected to be between $7 million and $11 million for the year [49] Product Lines - **Fracturing Systems**: Represents about 60% of revenue, helping customers maximize resource recovery [8][10] - **Repeat Precision**: Second-largest product line, expanding its offerings to capture additional market share [11][12] - **Tracer Diagnostics**: Acquired in 2017, provides cost-effective services to improve well designs and field development strategies [13][14] - **Well Construction**: Focuses on technologies that assist in drilling longer laterals, enhancing economic returns [15][16] Strategic Initiatives - Three core business strategies introduced in late 2022: 1. Build on leading market positions in fracturing systems and tracer diagnostics [17] 2. Capitalize on offshore and international opportunities, with international revenue doubling from 5% to 10% of total revenue [20] 3. Commercialize innovative solutions to complex customer challenges [19][21] - Recent acquisition of ResMetrix enhances tracer diagnostics capabilities and expands market presence in the Middle East [28][30] Market Dynamics - North American market for unconventional development is maturing, with customers focusing on value over volume [40] - International markets, particularly in the North Sea and Middle East, are seen as growth opportunities [41][42] - Tracer diagnostics is a discretionary service, but its use is expected to grow as operators seek to optimize production profiles [44][46] Cash Management and Future Outlook - The company maintains a strong balance sheet with approximately $25 million in cash and $17 million available through a revolving credit facility [35] - Limited capital expenditure (CapEx) of about 1-2% of revenue, allowing for operational leverage and free cash flow generation [52][54] - The management is open to strategic acquisitions but also considers stock buybacks if suitable opportunities do not arise [56][59] Conclusion - NCS Multistage Holdings presents a compelling investment opportunity with a strong growth track record, innovative technology, and a capital-light business model that supports free cash flow generation [33][34]
Here's Why Momentum in NCS Multistage (NCSM) Should Keep going
ZACKS· 2025-08-18 13:50
Core Viewpoint - The article emphasizes the importance of identifying and sustaining stock price trends for successful short-term investing, highlighting the need for strong fundamentals and positive earnings revisions to maintain momentum [1][2]. Group 1: Stock Performance - NCS Multistage (NCSM) has shown a solid price increase of 12.6% over the past 12 weeks, indicating investor confidence in its potential upside [4]. - The stock has also increased by 10.6% over the last four weeks, suggesting that the upward trend is still intact [5]. - NCSM is currently trading at 81.4% of its 52-week high-low range, indicating a potential breakout opportunity [5]. Group 2: Fundamental Strength - NCSM holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for near-term price movements [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term performance [7]. Group 3: Investment Strategy - The article suggests that investors can utilize the "Recent Price Strength" screen to identify stocks like NCSM that are on an upward trend supported by strong fundamentals [3][8]. - It also mentions that there are over 45 Zacks Premium Screens available for investors to find stocks that align with their investment strategies [8].
NCS Multistage Holdings, Inc. to Participate in Upcoming Investor Conferences
Globenewswire· 2025-08-07 20:05
Company Overview - NCS Multistage Holdings, Inc. is a leading provider of highly engineered products and support services for optimizing oil and natural gas well construction, completions, and field development strategies [4] - The company primarily serves exploration and production companies for onshore and offshore wells, especially those drilled with horizontal laterals in both unconventional and conventional formations [4] - NCS's products and services are utilized across North America and selected international markets, including the North Sea, Middle East, Argentina, and China [4] - The company's common stock is traded on the Nasdaq Capital Market under the symbol "NCSM" [4] Upcoming Investor Conferences - Ryan Hummer, the CEO of NCS, is scheduled to present at the EnerCom Denver Conference on August 19, 2025, at 8:30 a.m. Mountain Time [1] - NCS will participate in the Sidoti Investor Conference with a virtual presentation on August 21, 2025, at 9:00 a.m. Central Time, along with virtual one-on-one meetings with investors [2] - The company will also present at the Emerging Growth Conference on August 21, 2025, at 3:40 p.m. Central Time, with registration required for attendance [3] - Webcasts of the presentations will be available on the company's website for approximately 90 days following the events [3]
Is Advantage Oil & Gas (AAVVF) Outperforming Other Oils-Energy Stocks This Year?
ZACKS· 2025-08-07 14:41
Investors interested in Oils-Energy stocks should always be looking to find the best-performing companies in the group. Is Advantage Energy (AAVVF) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Advantage Energy is one of 241 individual stocks in the Oils-Energy sector. Collectively, these companies sit at #16 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the ave ...
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) 2025 Q2
Newsfile· 2025-08-04 20:34
Core Insights - NCS Multistage Holdings, Inc. (NCSM) reported total revenues of $36.5 million in Q2 2025, reflecting a 22.8% year-over-year increase, driven by strong fracturing systems activity and frac plug sales in the U.S. and Canada [1][5] - The company experienced a 52% sequential revenue decline in Canada due to spring break-up, while international revenues decreased year-over-year but increased 67.2% sequentially, supported by higher equipment sales in the North Sea [1][5] - U.S. revenues rose 45% sequentially as previously delayed projects resumed, with adjusted gross margins at 35.7%, down from 40.3% in Q2 2024 [1][5] Financial Performance - Adjusted EBITDA improved to $2.2 million, and earnings per share (EPS) was reported at $0.34, which includes a $1.4 million tax benefit [5] - The acquisition of ResMetrics was completed in Q2 2025, expected to contribute $4-5 million in revenue and $1-1.5 million in EBITDA for FY25 [5] Future Outlook - The company anticipates modest revenue and margin growth through FY25, supported by resilience in core product lines and contributions from the recent acquisition of ResMetrics [1]
NCS Multistage(NCSM) - 2025 Q2 - Quarterly Report
2025-08-01 20:24
PART I. FINANCIAL INFORMATION [Item 1. Financial Statements (Unaudited)](index=3&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) This section presents the unaudited condensed consolidated financial statements, including balance sheets, statements of operations, cash flows, and accompanying notes [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets increased to $158.0 million, while total liabilities decreased and total equity rose as of June 30, 2025 Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Current Assets** | $110,970 | $105,570 | | **Total Assets** | **$157,977** | **$152,812** | | **Total Current Liabilities** | $23,806 | $25,419 | | **Total Liabilities** | **$33,998** | **$36,703** | | **Total Equity** | **$123,979** | **$116,109** | [Condensed Consolidated Statements of Operations](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) The company reported a net income of $0.9 million in Q2 2025, a significant turnaround driven by a 22.8% revenue increase Q2 and H1 2025 vs 2024 Statement of Operations (in thousands, except per share data) | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :--- | :--- | :--- | :--- | :--- | | **Total Revenues** | $36,454 | $29,690 | $86,459 | $73,548 | | **Income (Loss) from Operations** | $(2,030) | $(4,150) | $2,259 | $(1,649) | | **Net Income (Loss) Attributable to NCS** | $924 | $(3,095) | $4,980 | $(1,025) | | **Diluted EPS** | $0.34 | $(1.21) | $1.84 | $(0.41) | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash provided by operating activities decreased to $1.9 million for H1 2025, with overall cash and equivalents decreasing by $0.5 million Six Months Ended June 30 Cash Flow Summary (in thousands) | Cash Flow Activity | 2025 | 2024 | | :--- | :--- | :--- | | **Net cash provided by operating activities** | $1,876 | $4,099 | | **Net cash used in investing activities** | $(474) | $(393) | | **Net cash used in financing activities** | $(2,240) | $(1,669) | | **Net change in cash and cash equivalents** | $(508) | $1,894 | [Notes to Unaudited Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) Notes detail financial aspects including Canada's market growth, ABL facility, ongoing patent litigation, a deferred tax benefit, and a subsequent acquisition - Canada is the company's largest market, with revenues growing **27.4% to $55.7 million** for the six months ended June 30, 2025, compared to the prior year period[27](index=27&type=chunk) - The company has an undrawn ABL Facility with an available borrowing base of **$17.2 million** as of June 30, 2025. Total debt of **$7.7 million** consists solely of finance leases[42](index=42&type=chunk)[45](index=45&type=chunk) - The company is involved in ongoing patent litigation. An appeal in a Canadian case against Kobold was heard in April 2025, with a decision expected by late 2025 or early 2026. Favorable U.S. verdicts against Nine Energy and TCO are also under appeal[56](index=56&type=chunk)[58](index=58&type=chunk) - A deferred income tax benefit of **$1.4 million** was recorded during the period due to the reversal of a valuation allowance against its Canadian subsidiary's deferred tax assets[66](index=66&type=chunk) - On July 31, 2025, the company acquired Reservoir Metrics, LLC for **$5.9 million** in cash and assumed debt, plus a potential earn-out[69](index=69&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=19&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial performance, Q2 2025 revenue growth, market outlook, key risks, and the company's sufficient liquidity position [Overview and Outlook](index=19&type=section&id=Overview%20and%20Outlook) NCS provides oil and gas well optimization products, with a 2025 outlook of stable Canadian activity, U.S. decline, and international growth, facing commodity and tariff risks - The company acquired Reservoir Metrics, LLC on July 31, 2025, to expand and complement its existing tracer diagnostics offerings[74](index=74&type=chunk) - Management's 2025 outlook anticipates: (i) stable or slightly decreased activity in Canada, (ii) continued decline in the U.S. market, and (iii) potential activity increases in international markets where NCS participates[76](index=76&type=chunk) - The company faces risks from competitive pressures, cost inflation, and trade tariffs on steel and chemicals from China, which could negatively impact costs and margins[78](index=78&type=chunk)[79](index=79&type=chunk) [Market Conditions](index=20&type=section&id=Market%20Conditions) Q2 2025 saw volatile commodity prices and declining U.S. and Canadian rig counts, reflecting seasonal market conditions Average Quarterly Commodity Prices | Quarter Ended | WTI Crude (per Bbl) | Henry Hub Natural Gas (per MMBtu) | | :--- | :--- | :--- | | 3/31/2025 | $71.78 | $4.14 | | 6/30/2025 | $64.57 | $3.19 | Average Quarterly Drilling Rig Count | Quarter Ended | U.S. Land | Canada Land | | :--- | :--- | :--- | | 6/30/2024 | 583 | 134 | | 3/31/2025 | 574 | 214 | | 6/30/2025 | 559 | 127 | [Results of Operations](index=24&type=section&id=Results%20of%20Operations) Q2 2025 total revenues increased **22.8% to $36.5 million**, driven by product sales, resulting in net income despite a gross margin decrease due to mix shift Q2 2025 vs Q2 2024 Results (in thousands) | Metric | Q2 2025 | Q2 2024 | Change % | | :--- | :--- | :--- | :--- | | **Total Revenues** | $36,454 | $29,690 | 22.8% | | Product Sales | $27,776 | $19,022 | 46.0% | | Services | $8,678 | $10,668 | (18.7)% | | **Total Gross Profit** | $12,269 | $11,318 | 8.4% | | **Total Gross Margin** | 33.7% | 38.1% | - | | **Net Income (Loss)** | $1,698 | $(2,839) | 159.8% | - Revenue growth in Q2 was primarily driven by increased fracturing systems activity in Canada and higher frac plug sales by Repeat Precision in the United States[96](index=96&type=chunk) - SG&A expenses decreased by **8.1% to $13.6 million** in Q2 2025, mainly due to lower professional fees and payroll expenses[98](index=98&type=chunk) [Liquidity and Capital Resources](index=29&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains sufficient liquidity with **$25.4 million** cash and an undrawn ABL facility, despite a decrease in H1 2025 operating cash flow to **$1.9 million** - As of June 30, 2025, the company had **$25.4 million** in cash and cash equivalents and **$17.2 million** available under its ABL facility, with no outstanding borrowings[109](index=109&type=chunk) - Planned capital expenditures for the full year 2025 are estimated to be between **$1.4 million and $1.6 million**[112](index=112&type=chunk) - Net cash provided by operating activities for the first six months of 2025 was **$1.9 million**, a decrease from **$4.1 million** in the same period of 2024[115](index=115&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=33&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) Market risk exposure remains largely unchanged since year-end 2024, though customer concentration risk increased due to a merger - There has been no material change in market risk exposure since year-end 2024[126](index=126&type=chunk) - A business combination of two large customers resulted in a single entity constituting **17%** of trade receivables as of June 30, 2025, increasing customer concentration risk[126](index=126&type=chunk) [Controls and Procedures](index=33&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal control - Management concluded that disclosure controls and procedures were effective as of June 30, 2025[127](index=127&type=chunk) - No material changes in internal control over financial reporting were identified during the quarter ended June 30, 2025[128](index=128&type=chunk) PART II. OTHER INFORMATION [Legal Proceedings](index=34&type=section&id=Item%201.%20Legal%20Proceedings) This section refers to Note 10 of the financial statements for detailed information on ongoing legal proceedings - For information regarding legal proceedings, the report refers to "Note 10. Commitments and Contingencies" in the financial statements[130](index=130&type=chunk) [Risk Factors](index=34&type=section&id=Item%201A.%20Risk%20Factors) No material changes to the risk factors disclosed in the company's 2024 Annual Report on Form 10-K have occurred - There have been no material changes to the risk factors disclosed in the company's 2024 Annual Report[131](index=131&type=chunk) [Other Information](index=34&type=section&id=Item%205.%20Other%20Information) No director or officer adopted or terminated a Rule 10b5-1 trading arrangement during the second quarter of 2025 - No director or officer adopted or terminated a Rule 10b5-1 trading plan during the quarter ended June 30, 2025[132](index=132&type=chunk) [Exhibits](index=35&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO and CFO certifications and Inline XBRL data files - The report lists filed exhibits, including CEO and CFO certifications pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act[133](index=133&type=chunk)
NCSM Q2 Profit Jumps 23%
The Motley Fool· 2025-08-01 18:03
Core Insights - Ncs Multistage reported a significant turnaround to profitability in Q2 2025, with GAAP revenue of $36.5 million, exceeding analyst estimates by 31.6% [1][2] - The company achieved GAAP earnings per share of $0.34, contrasting with an expected loss of $1.29, indicating strong operational performance despite cost pressures and margin contraction [1][2] Financial Performance - Revenue increased by 23.0% year-over-year, driven by strong activity in Canada and the U.S., with Canadian revenue rising to $17.97 million and U.S. revenue to $13.61 million [5][6] - Adjusted EBITDA more than doubled to $2.2 million, while free cash flow for the first half of 2025 decreased to $1.4 million from $3.7 million in the same period of 2024 [2][7] - Adjusted gross margin fell by 4.0 percentage points to 36%, attributed to a shift towards lower-margin products and increased cost pressures [6][11] Business Overview and Strategy - Ncs Multistage specializes in oil and gas well completions, focusing on pinpoint stimulation technology to enhance hydrocarbon extraction efficiency [3][4] - The company aims to expand the adoption of its pinpoint stimulation technology and introduce new products like sliding sleeves and tracer diagnostics [4][8] Market Dynamics - Canadian revenue surged by approximately 49%, while U.S. revenue grew by about 15.5%, despite a decline in the overall Canadian rig count [5] - International revenue decreased by 16.6%, primarily due to a slowdown in tracer diagnostics work in the Middle East [5] Innovation and Acquisitions - The company acquired ResMetrics for $5.9 million, which generated over $10 million in revenue and has EBITDA margins above 30%, enhancing Ncs's tracer diagnostics capabilities [10] - Ongoing innovation includes the commercialization of new products and expansion of field trials for advanced tracer diagnostics systems [9][10] Future Outlook - Management did not provide updated guidance for Q3 or full fiscal year 2025, maintaining a cautious tone due to deteriorating market conditions and potential risks affecting customer activity [12][13] - Investors are expected to monitor the adoption of new technologies and the impact of cost pressures on future performance [13]
NCS Multistage(NCSM) - 2025 Q2 - Earnings Call Transcript
2025-08-01 13:32
Financial Data and Key Metrics Changes - The company's second quarter revenue for 2025 was $36,500,000, representing a year-over-year improvement of 23% and the highest second quarter revenue since 2019 [18] - Adjusted EBITDA for the second quarter was $2,200,000, an improvement compared to $900,000 for the same period in 2024 [21] - Net income for the second quarter was $900,000, or diluted earnings per share of $0.34, compared to a net loss of $3,100,000 or a loss per share of $1.21 in the prior year [20] - Adjusted gross profit was $13,000,000, with an adjusted gross margin of 36%, down from 40% a year ago [19] Business Line Data and Key Metrics Changes - Revenue in Canada for 2025 was $56,000,000, increasing 27% compared to the same period in 2024, driven by strong performance in fracturing systems [7] - U.S. revenues improved by 15%, reflecting an increase in fracturing system sales and higher frac plug sales at Repeat Precision [18] - International revenues decreased by 17%, primarily due to the timing of tracer diagnostic projects in the Middle East [18] Market Data and Key Metrics Changes - The Canadian rig count was approximately 10% to 15% below the previous year, impacting the company's performance [38] - The company expects continued success in the North Sea, with an increase in customers from two in 2022 to seven in 2025 [10] - The Middle East market is seeing increased well construction sales, partially offsetting delays in tracer diagnostics projects [10] Company Strategy and Development Direction - The company aims to build upon its leading market positions, capitalize on international opportunities, and commercialize innovative solutions [11] - The acquisition of ResMetrix is expected to enhance the company's tracer diagnostics capabilities and expand its presence in the Middle East [15] - The company maintains a strong balance sheet and liquidity position, utilizing cash on hand for strategic acquisitions [16] Management's Comments on Operating Environment and Future Outlook - Management expressed caution regarding the second half of 2025 due to deteriorating market conditions, including a decline in U.S. rig counts and potential oversupply in the oil market [25] - The company is maintaining a wider than normal range for annual operating guidance, with expected revenue growth of 6% at the midpoint [25] - Management noted a cautiously optimistic tone among customers, with a focus on the fourth quarter and potential impacts from OPEC supply [48] Other Important Information - The total purchase price for ResMetrics is up to a maximum cash amount of $7,150,000, with an earn-out component of up to $1,250,000 [22] - The company expects ResMetrics to contribute an additional $4,000,000 to $5,000,000 of revenue and $1,000,000 to $1,500,000 of adjusted EBITDA for the last five months of 2025 [27] Q&A Session Summary Question: Opportunities for cross-selling post-acquisition of ResMetrics - Management indicated that there are distinct customer bases for ResMetrics and the existing tracer diagnostics business, with potential revenue synergy opportunities as new technologies are introduced to a broader customer set [33][34] Question: Targeting new geographies and market uncertainty - Management expressed interest in continuing momentum in the North Sea and expanding into other offshore markets, while remaining cautious due to market uncertainties [35] Question: Factors needed to tighten guidance range - Management highlighted the importance of Canadian rig counts and indicated that narrowing the guidance range would depend on improvements in rig activity [36][38] Question: Margin opportunities and integration of ResMetrics - Management discussed potential operational synergies and cost reductions through the adoption of best practices, with a long-term goal of generating $1,000,000 to $2,000,000 in operational synergies [42][43] Question: Customer mindset in the current market environment - Management noted a cautiously optimistic tone among customers, with a focus on the potential impacts of OPEC supply and a reassessment of forecasts in Canada [46][50]
NCS Multistage(NCSM) - 2025 Q2 - Earnings Call Transcript
2025-08-01 13:30
Financial Data and Key Metrics Changes - The company's second quarter revenue for 2025 was $36,500,000, representing a year-over-year improvement of 23% [18] - Adjusted EBITDA for the second quarter was $2,200,000, an improvement compared to $900,000 for the same period in 2024 [21] - Net income for the second quarter was $900,000, or diluted earnings per share of $0.34, compared to a net loss of $3,100,000 or a loss per share of $1.21 in the prior year [20] Business Line Data and Key Metrics Changes - Revenue in Canada for 2025 was $56,000,000, increasing 27% compared to the same period in 2024, driven by strong performance in fracturing systems [7] - U.S. revenues improved by 15%, reflecting an increase in fracturing system sales and higher frac plug sales at Repeat Precision [18] - International revenues decreased by 17%, primarily due to the timing of tracer diagnostic projects in the Middle East [18] Market Data and Key Metrics Changes - The Canadian rig count was approximately 10% to 15% below the previous year, impacting the company's performance [34] - The company expects continued success in the North Sea, with an increase in customers from two in 2022 to seven in 2025 [10] Company Strategy and Development Direction - The company aims to build upon its leading market positions, particularly in Canada, and capitalize on international and offshore opportunities [8][9] - The acquisition of ResMetrics is expected to enhance the company's tracer diagnostics capabilities and expand its market presence in the Middle East [15][16] - The company is focused on commercializing innovative solutions to complex customer challenges, with ongoing field trials for new products [11] Management's Comments on Operating Environment and Future Outlook - Management expressed caution regarding the second half of 2025 due to deteriorating market conditions, including a decline in U.S. rig counts and potential oversupply in the oil market [24] - The company maintains a strong balance sheet and liquidity position, expecting to generate positive free cash flow in 2025 [27] Other Important Information - The total purchase price for ResMetrics is up to $7,150,000, with an earn-out component of up to $1,250,000 to be paid in 2026 [21] - The company expects third quarter total revenue in the range of $42,000,000 to $46,000,000 [22] Q&A Session Summary Question: Opportunities for cross-selling post-acquisition - Management indicated that there are distinct customer bases for ResMetrics and the existing tracer diagnostics business, suggesting potential revenue synergy opportunities as they integrate offerings [30] Question: Targeting new geographies - Management expressed excitement about expanding in the North Sea and the Middle East, while also considering other offshore markets [32] Question: Factors to tighten guidance range - Management noted that the Canadian rig count is a key factor, with a need for it to recover to provide more confidence in tightening guidance [34] Question: Margin improvement opportunities - Management highlighted that operational synergies could lead to cost reductions, but refrained from specifying margin percentages [40] Question: Customer mindset in volatile market conditions - Management observed a cautiously optimistic tone among customers, with a wait-and-see approach regarding oil prices and market conditions [44]
NCS Multistage(NCSM) - 2025 Q2 - Earnings Call Presentation
2025-08-01 12:30
Financial Performance & Metrics - As of July 29, 2025, the share price was $30.25, with 2.7 million diluted shares outstanding, resulting in an equity value of $82.7 million[10] - The company's enterprise value is $82.5 million, calculated with $7.7 million in total debt, $17.5 million in non-controlling interest, and $25.4 million in cash[10] - The company has a strong cash position, with net debt (cash) at $(17.7) million and net working capital of $64.0 million[10] - Q2 2025 total revenue reached $36.5 million, a 23% increase compared to Q2 2024[53] - The company's adjusted EBITDA for Q2 2025 was $2.2 million, a $1.3 million increase compared to Q2 2024[53] - The company anticipates full year 2025 revenue to be between $168 million and $176 million, representing a 6% year-over-year increase at the midpoint[57] - The company projects adjusted EBITDA for full year 2025 to be between $21 million and $24 million[57] Strategic Initiatives & Acquisitions - NCS acquired ResMetrics in July 2025 for up to $7.15 million, with $5.90 million in cash and assumed debt at close, and an earnout of up to $1.25 million[29, 42] - ResMetrics is expected to contribute $4 million to $5 million in revenue to NCS in 2025 (August through December)[42] Market Expansion & Diversification - NCS has expanded its addressable market, with revenue increasing from $98 million in 2016 to $163 million in 2024[38] - The customer base has grown from over 140 customers in 2016 to over 200 customers in 2024[38]